Detalhe da pesquisa
1.
The differential effect of modern intravenous iron on fibroblast growth factor 23 and phosphate in non-dialysis dependent CKD - the exploratory randomized controlled double-blind ExplorIRON-CKD study.
BMC Nephrol
; 25(1): 54, 2024 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38347520
2.
Methodology and Baseline Data of a Comparative Exploratory Double-Blinded Randomized Study of Intravenous Iron on Fibroblast Growth Factor 23 and Phosphate in Chronic Kidney Disease.
Kidney Blood Press Res
; 48(1): 151-164, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37015198
3.
Markers of Oxidative Stress, Inflammation and Endothelial Function following High-Dose Intravenous Iron in Patients with Non-Dialysis-Dependent Chronic Kidney Disease-A Pooled Analysis.
Int J Mol Sci
; 23(24)2022 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36555659
4.
Patient reported outcome measures and cardiovascular outcomes following high dose modern intravenous iron in non-dialysis dependent chronic kidney disease: secondary analysis of ExplorIRON-CKD.
Sci Rep
; 13(1): 18401, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37884522
5.
Analysis of oxidative stress, inflammation and endothelial function following intravenous iron in chronic kidney disease in the Iron and Heart Trial.
Sci Rep
; 12(1): 6853, 2022 04 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35477731
6.
Hypophosphataemia, fibroblast growth factor 23 and third-generation intravenous iron compounds: a narrative review.
Drugs Context
; 102021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33519940
7.
An evaluation of ferric derisomaltose as a treatment for anemia.
Expert Rev Hematol
; 14(1): 7-29, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33317356
8.
The comparative effects of intravenous iron on oxidative stress and inflammation in patients with chronic kidney disease and iron deficiency: a randomized controlled pilot study.
Kidney Res Clin Pract
; 40(1): 89-98, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745264
9.
Point-of-care testing technologies for the home in chronic kidney disease: a narrative review.
Clin Kidney J
; 14(11): 2316-2331, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34751234
10.
Improving the safety of intravenous iron treatments for patients with chronic kidney disease.
Expert Opin Drug Saf
; 20(1): 23-35, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33203251
11.
Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
Trials
; 21(1): 273, 2020 03 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32183861
12.
Colorectal Cancer Presenting as Single Pulmonary Hilar Lymph Node Metastasis.
Case Rep Surg
; 2018: 5474919, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29593929
13.
The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia.
Kidney Int Rep
; 7(2): 322-326, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35155871
14.
Cardiac complications in end-stage renal disease: a shared care challenge.
Br J Cardiol
; 27(2): 10, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-35747081
15.
Breathlessness at rest is not the dominant presentation of patients admitted with heart failure.
Eur J Heart Fail
; 16(12): 1283-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25452165